Details for New Drug Application (NDA): 014691
✉ Email this page to a colleague
NDA 014691 describes ALKERAN, which is a drug marketed by Apotex and is included in two NDAs. Additional details are available on the ALKERAN profile page.
The generic ingredient in ALKERAN is melphalan. There are twelve drug master file entries for this compound. Additional details are available on the melphalan profile page.
The generic ingredient in ALKERAN is melphalan. There are twelve drug master file entries for this compound. Additional details are available on the melphalan profile page.
Medical Subject Heading (MeSH) Categories for 014691
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
